Clinical trial
Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid…
NCT00107523 · Fred Hutchinson Cancer Center, Other · Completed
Key facts
| NCT number | NCT00107523 |
|---|---|
| Title | Pravastatin, Idarubicin, and Cytarabine in Treating Patients With Acute Myeloid Leukemia |
| Official title | A Phase I Trial Evaluating the Effect of the Addition of HMGCoA-Reductase Inhibition With Pravastatin to Salvage Chemotherapy Idarubicin-HDAC in Patients With Relapsed or Refractory Acute Myelogenous Leukemia |
| Lead sponsor | Fred Hutchinson Cancer Center, Other |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Leukemia |
| Intervention type | Drug |
| Interventions | cytarabine, idarubicin, pravastatin |
| Start date | Jan 1, 2005 |
| Completion | Oct 1, 2005 |
| First posted | Apr 6, 2005 |
| Last update posted | Sep 21, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: